Please provide your email address to receive an email when new articles are posted on . The VRBPAC voted unanimously to recommend that future COVID-19 vaccines be monovalent. The vote was based on ...

Credit: Getty Images. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the US. The Food and Drug Administration (FDA) has authorized the use of the mRNA ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Compared with a monovalent vaccine, a fourth dose of a ...

Pfizer/BioNTech’s bivalent COVID-19 booster vaccine, approved in many parts of the world in late 2022, is no more likely than the monovalent version to increase the risk of cardiovascular events, ...

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers evaluated the durability of protection ...

Hello again to a monovalent COVID-19 vaccine. Goodbye to the bivalent shot. That was the message Thursday from an FDA advisory committee, which decided unanimously that COVID vaccines this fall should ...

An advisory committee for the Food and Drug Administration on Thursday voted unanimously (21 to 0) to recommend updating COVID-19 vaccines for the 2023-2024 period to be a monovalent formula targeting ...

In a recent study published in Influenza and other respiratory viruses, researchers estimated the immune protection conferred by monovalent-type coronavirus disease 2019 (COVID-19) messenger ...

The FDA has authorized additional omicron bivalent booster doses for people 65 and older and those with compromised immune systems, the agency said April 18. Under the amended emergency use ...

The Food and Drug Administration on Tuesday altered its authorizations for mRNA-based COVID-19 vaccines, retiring the original monovalent versions entirely, streamlining immunizations for the ...